Abstract:OBJECTIVE:To evaluate the association of colorectal adenoma with metabolic syndrome (MS) and relevant parameters.METHODS:Clinical data of 289 subjects who underwent screening colonoscopy in the University of Hong Kong-Shenzhen Hospital from January 2014 to June 2015 were retrospectively analyzed, including 130 normal subjects (normal group) and 159 cases with colorectal adenoma confirmed by pathology(adenoma group). Levels of MS-associated parameters were compared between the two groups, and the association of metabolic diseases with colorectal adenoma was examined.RESULTS:The gender, smoking and drinking habit, regular physical activity, family history of colorectal cancer, and consumption history of long-term non-steroidal anti-inflammatory drugs were not significantly different between two groups (all P>0.05). As compared to normal group, adenoma group had higher body mass index (BMI) [(23.5±3.2) kg/m(2) vs. (22.7±2.8) kg/m(2), t=1.97, P=0.050], larger abdominal circumference [(83.4±10.3) cm vs. (79.6±13.8) cm, t=2.46, P=0.015], higher serum high-density lipoprotein level [(1.3±0.3) mmol/L vs. (1.2±0.3) mmol/L, t=2.03, P=0.044], and higher serum cholesterol [(5.4±1.0) mmol/L vs. (5.0±1.1) mmol/L, t=2.39, P=0.018]. No significant difference was demonstrated in comparing hip circumference and waist-hip ratio, as well as serum fasting glucose and triglyceride(all P>0.05). Higher incidence of colorectal adenoma was found in subjects with MS [69.8%(37/53) vs. 1.7%(122/236), P=0.017], overweight or obesity [65.1% (56/86) vs. 50.7%(103/203), P=0.025], hypertension [67.3%(37/55) vs. 52.1%(122/234), P=0.046] and hypercholesterolemia [66.7%(64/96) vs. 49.2%(95/193), P=0.005].CONCLUSIONS:Metabolic syndrome increased the risk of developing colorectal adenoma. The mechanism may be related to higher serum cholesterol and high density lipoprotein, which may lead to the elevated catabolism of serum cholesterol. Screening colonoscopy should be performed for patients diagnosed as metabolic syndrome, especially for those with central obesity and hypercholesterolemia, thus early diagnosis and treatment of colorectal adenoma may be available.

[Study on Clinicopathological Correlations Between Metabolic Syndrome and Colorectal Carcinoma].

Clinical Study on the Correlation Between Metabolic Syndrome and Colorectal Carcinoma

Metabolic syndrome is an important factor for the evolution of prognosis of colorectal cancer: survival, recurrence, and liver metastasis.

Correlation Between Colon Polyps and Metabolic Syndrome and HP Infection Status

[Association of Metabolic Syndrome and Colorectal Cancer].

Study on the Correlation of Metabolic Syndrome and the Incidence of Colorectal Neoplasms

The Relationship Between Colorectal Tumors and Metabolic Syndrome

Study on relationship between metabolic syndrome and breast cancer

New Study Progress on the Relationship between Metabolic Syndrome and Cancer

Clinical and genomic characteristics of metabolic syndrome in colorectal cancer

[Association of Colorectal Adenoma and Metabolic Syndrome and Relevant Parameters].

Metabolic syndrome associated with adverse pathological features in patients with colorectal adenocarcinoma

Metabolic syndrome and the risk of prostate cancer

Interaction of Smoking and Metabolic Syndrome in Increasing the Recurrence Risk of Colorectal Cancer in a Chinese Male Cohort: a Retrospective Study

Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients.

Study on Relationship between Major Components of Metabolic Syndrome and Recurrence of Colorectal Adenomatous Polyp

Expression of Components of Metabolic Syndrome and Related Diseases in Patients with Colorectal Tumor at Different Stages

Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population

Relationship between metabolic syndrome and prostate cancer:a report of 185 cases

Metabolic Syndrome Components and the Risk of Colorectal Cancer: A Population-Based Prospective Study in Chinese Men.

The association between metabolic syndrome and renal cell carcinoma